In recognition of Alzheimer’s Disease Awareness Month, we’re featuring studies using innovative techniques to reveal new insights in Alzheimer’s disease (AD). Read our blog to learn how single-nucleus sequencing uncovered a unique transcriptional profile in AD-associated astrocytes.
BioLegend offers a wide range of solutions to advance AD research, including proteogenomics and microscopy reagents. Explore our gold-standard antibodies to identify astrocytes and the pathological hallmarks of the disease. |
Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
Follow Us